West pharmaceutical services, inc. (WST)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08
Cash flows from operating activities:
Net income

241,700

206,900

150,700

143,600

95,600

127,100

112,300

80,700

75,500

65,300

72,600

86,600

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation

100,000

101,700

94,300

88,100

86,100

84,800

81,000

72,800

71,100

68,800

63,900

56,100

Amortization

3,400

2,700

2,400

2,600

3,800

5,200

4,200

4,100

4,600

4,400

4,200

4,500

Loss on debt extinguishment

-

-

-

-

-

-

-200

-11,600

0

0

-

-

Stock-based compensation

24,400

15,100

16,100

19,500

29,600

18,600

21,200

15,500

8,400

7,800

7,500

6,400

Pension settlement charge

-3,500

0

0

2,100

0

0

-

-

-

-

-

-

Pension settlement charge

-

-

-

-

-50,400

0

0

-

-

-

-

-

Non-cash restructuring charges

2,300

2,200

700

17,500

0

0

-

6,200

0

4,400

5,800

0

Venezuela deconsolidation

0

0

-11,100

0

0

-

-

-

-

-

-

-

Contingent consideration payments in excess of acquisition-date liability

500

600

0

0

-

-

-

-

-

-

-

-

Loss on sales of equipment

-800

-1,800

-1,600

-700

-400

-300

-400

-1,700

200

-700

-900

0

Deferred income taxes

15,300

900

41,700

21,500

-8,900

7,000

1,700

5,300

2,900

-1,800

-4,800

7,300

Pension and other retirement plans, net

-2,600

-7,900

-6,900

-6,500

-28,800

-25,000

8,000

-2,700

-4,500

5,400

-5,900

4,900

Equity in undistributed earnings of affiliates, net of dividends

6,700

5,900

7,000

6,800

5,000

4,500

4,800

4,500

6,000

4,200

2,700

-700

Changes in assets/liabilities, net of acquisitions:
Increase in accounts receivable

33,300

43,800

39,700

23,300

14,100

6,300

9,100

25,700

25,500

-9,400

6,000

1,900

Increase in inventories

18,600

7,000

3,600

21,200

11,400

16,200

13,900

8,900

9,300

20,700

6,400

-13,400

Decrease (increase) in other current assets

-2,600

6,200

-300

2,400

2,600

11,700

600

-5,800

3,100

3,900

100

-700

Increase in accounts payable

25,300

400

12,600

6,100

17,200

-3,500

4,600

5,800

24,600

-300

-700

-3,300

Other non-cash items, net

-9,600

-28,300

11,000

17,900

-100

-7,100

-15,300

-19,700

7,800

-3,000

2,400

-14,600

Net cash provided by operating activities

367,200

288,600

263,300

219,400

212,400

182,900

220,500

187,400

130,700

138,300

137,700

135,000

Cash flows from investing activities:
Capital expenditures

126,400

104,700

130,800

170,200

131,600

111,900

151,900

131,300

95,400

71,100

104,900

138,600

Purchase of investment in affiliated companies

85,100

0

0

-

-

-

-

-

-

-

-

-

Acquisition of business

18,900

0

0

-

-

-

-

-

-

-

-

-

Acquisition of patents and other long-term assets

-

-

-

-

-

200

3,900

700

1,400

2,700

2,900

500

Sales and maturities of short-term investments

-

-

-

-

-

16,800

19,100

45,600

15,600

-

-

-

Purchases of short-term investments

-

-

-

-

-

9,300

14,200

31,200

41,200

-

-

-

Purchase of cost-method investments

-

-

-

8,400

1,500

500

-

-

-

-

-

-

Cash related to deconsolidated Venezuelan subsidiary

0

0

6,000

0

0

-

-

-

-

-

-

-

Acquisition of businesses, net of cash acquired

-

-

-

-

-

-

-

-

-

3,700

16,900

0

Sales of investments

-

-

-

-

-

-

-

-

-

8,900

5,300

16,800

Purchases of investments

-

-

-

-

-

-

-

-

-

7,200

2,700

0

Other, net

-2,400

-3,900

-3,200

-2,800

-3,600

-1,100

-1,000

-1,600

-1,900

-1,800

-200

-2,600

Net cash used in investing activities

-228,000

-100,800

-133,600

-175,800

-129,500

-104,000

-149,900

-116,000

-120,500

-74,000

-121,900

-119,700

Cash flows from financing activities:
Borrowings under revolving credit agreements

108,500

0

0

-

71,400

263,400

292,700

568,300

193,400

26,600

16,400

9,500

Repayments under revolving credit agreements

-

-

-

-

71,400

283,400

311,000

502,600

199,900

39,800

22,300

21,800

Repayments of Lines of Credit

136,300

0

0

-

-

-

-

-

-

-

-

-

Issuance of long-term debt

90,000

0

0

-

-

-

43,200

168,100

200

0

-

-

Repayments of Long-term Debt

100

100

34,900

69,800

27,400

2,300

30,500

215,900

700

-

-

-

Issuance of long-term debt

1,200

0

0

-

1,000

0

0

7,500

300

1,700

0

0

Payment of long-term debt

-

-

-

-

-

-

-

-

-

0

-

-

Changes in other debt

-

-

-

-

-

-

-

-

-

-1,100

-4,300

3,100

Acquisition of noncontrolling interest

-

-

-

-

-

-

-

-

-

-

-

8,500

Dividend payments

45,100

42,100

39,100

35,800

32,400

29,100

26,700

24,900

23,200

21,700

20,100

18,600

Contingent consideration payments up to amount of acquisition-date liability

0

0

-700

-300

-100

-300

-100

-

-

-

-

-

Proceeds from stock-based compensation awards

25,100

27,400

35,700

25,900

12,700

14,300

21,700

8,700

3,900

3,700

5,000

6,200

Employee stock purchase plan contributions

5,400

4,900

4,400

3,800

3,200

2,800

2,500

2,200

1,900

-

-

-

Excess tax benefit from employee stock plans

-

-

-

18,200

9,100

7,900

8,300

4,900

3,500

2,100

4,000

5,900

Shares purchased under share repurchase programs

83,100

70,800

74,400

52,200

0

0

-

-

-

2,100

1,300

5,200

Shares repurchased for employee tax withholdings

-

-

-

3,700

5,600

4,100

5,200

4,700

3,500

-

-

-

Net cash used in financing activities

-36,800

-80,700

-109,000

-113,900

-41,500

-30,800

-5,100

-3,400

-24,700

-34,000

-22,600

-29,400

Effect of exchange rates on cash

-700

-5,600

12,200

-1,300

-22,100

-22,800

2,600

2,100

-3,900

-3,200

2,700

-7,100

Net decrease in cash and cash equivalents

101,700

101,500

32,900

-71,600

19,300

25,300

68,100

70,100

-18,400

27,100

-4,100

-21,200

Supplemental cash flow information:
Interest paid, net of amounts capitalized

8,600

8,400

8,000

8,600

14,700

16,700

16,900

15,300

18,200

16,800

15,500

15,900

Income taxes paid, net

47,500

42,000

31,000

48,100

33,100

37,400

34,400

16,100

20,400

16,500

19,000

25,000

Accrued capital expenditures

17,000

15,000

20,100

22,700

25,000

21,000

17,100

54,300

33,800

7,100

9,900

9,800

Purchase of investment in affiliated companies, treasury stock

4,900

0

0

-

-

-

-

-

-

-

-

-